On the wires:
Sumitomo will set up a special investigation into how it lost nearly $1.8B in Texas shale oil and Australian coal mining, after writedowns connected to the investments almost completely wipe out its full-year earnings forecast.
Most of the losses were incurred at the shale oil project it shares with Devon Energy (NYSE:DVN); in 2012, Sumitomo paid DVN $340M for 30% of the project in the Permian Basin, agreeing to supply another $1B to fund most of the cost of drilling wells, but now it says it wants to sell most of its share since it is “difficult to extract the oil and gas efficiently."
The company also plans to stop production at the Isaac Plains coal mine in Australia's Queensland state it co-owns with Vale (NYSE:VALE) by the end of January.
“Even by the standards of trading companies, this is not good,” says the co-head of Japan equities at Mirabaud Securities, drawing parallels to Mitsui's costly exposure to BP’s blowout in the Gulf of Mexico.
I don't know how old you are, but I've been to this rodeo many times.
I agree with much of what you said.
Unfortunately, although the news is not "new", it is different from historical patterns.
I also feel many stock valuations are ridiculous. .
Yes, the MMs (and their machines) control the markets. It's an extremely hostile environment for retail investors.
The commodities will come back..it's just a matter of when.
My conception of a "long term Hold" has a shorter expiration date...just like me.
Brazil's real falls to a five-year low and Petrobras (PBR -11.1%) plunges more than 10% at the open after a new poll showed Pres. Rousseff widening her lead over opposition candidate Marina Silva.
The real dropped 2.1% in early trading, and the currency has tumbled 11% so far in Q3 with volatility increasing as the Oct. 5 presidential vote approaches.
Over the weekend, Rousseff rejected rumors of soliciting funds from PBR for her campaign in 2010.
ITUB -7.6%, BBD -6.8%, GOL -5.4%, GFA -4.8%, BRFS -3.7%, VALE -2.8%, TSU -2.4%, BSBR -2.1%, SID -1.8%, ERJ -1.6%.
Brazil ETFs: EWZ, BRF, BRXX, EWZS, BRAQ, BRZU, BRAZ, BZQ, BRAF, UBR, BRZS, DBBR, FBZ
~ck (very long)
I think the overall market correction will be in the near term.
Political problems worldwide, the strong dollar and debt will be the contibuting factors.
You can read stories about Adaptimmune which just entered a partnership with GSK.
I haven't researched GSK enought to comment.
I'll stick to Vale/CLF comments on this MB. I've found people get annoyed with OT posts.
Yes. I held my biotechs. I have invested in the sector for many years. Thye are risky investments but I have the stomach for the FDA failures. I've made big money and lost big money. My latest is TTPH. Too expensive now but I'm in at $10. I bought more during the sell off. I own over 20 companies..some are in the tank.
Sometimes it's about knowing when to sell. I owned KERX for many years..I road it way down to $2. Then things changed and before FDA approval for Zerenex it went to $18...after approval it is now at $14...
It's all about the management, science, possible partnering with pharma and cash burn.
I have an old friend who is a retired top chemist from MRK. He and I exchange
thoughts on biotech companies.
I bought some of the commodities many years ago when they tanked.and the market was in the crapper...companies like FCX etc.. I remember I bought when Mark Haines (R.I.P.)on CNBC said it was the bottom. I had great respect for his opinions and jumped in..My friends thought I was insane. I made some nice $$.
My mistake was getting back in a few years ago..my coal stocks are really really bad performers.
OK..too much coffee this morning.
I hope you are right about CLF. I am seriously underwater and have been concerned about their long term outlook. I am considering taking a huge loss at year end unless I see some positive news.
I also own VALE...not as lare a position but same situation.
Not a good time to be in commodiities.
My biotech stocks have kept my portfolio from looking like a sea of red.
TTPH presents today ar a Biotech Conference in NYC...2:30 PM.
Could be interesting.
This has been a great stock to own.
Sentiment: Strong Buy
I live in Sarasota, so I'm very familiar with SNHY. I especially like Carlson.. I bought my original shares in the $20s. I also bought shares in the $30s.
I have some companies in my portfolio that I've had since the crash....Companies like SLB that have been very profitable. They are pricey now.
I sold some stocks and raised some cash over the last few months so I'll be buying again when things settle down.
Most of my commodities have taken a hit so I'm gun shy.
Sentiment: Strong Buy
I sold in the $10s around time of AMGN announcement and bought back today.
Hoping for the best.
I am more concerned about the overall market now that BABA hype is over.
Sentiment: Strong Buy
NEW YORK, Sept 18 (Reuters) - When Alibaba Group Holding Ltd begins trading on Friday the shares may not be able to avoid the kind of volatility typically seen in trading of eagerly anticipated IPOs, even as the bulk of the shares sold are expected to reside with 25 to 50 behemoth institutions.
Underwriters hope that allocating the majority of the Chinese e-commerce company's shares to institutional investors, thought of as being less likely than their retail counterparts to sell quickly, may prevent Aliba
The company is expected to sell about $22 billion in shares after the close of trading Thursday in what is expected to be one of the biggest IPOs in history.
"For this kind of large deal, it's very common to allocate the bulk of shares to the large institutionals who will hold it for the long run," said Josef Schuster, founder of Chicago-based IPOX Schuster LLC, which helps create index funds for IPOs.
Yet the line of fund managers who look set to dominate Alibaba's (Symbol : BABA
IPO does not guarantee investors will hang onto their shares for very long, especially if they do not get what they want out of the allocation, people watching the IPO said.
"The biggest pitfall is to ensure that the allocations stick," said one event-driven investor, who put in an order of shares, but did not want to be named.
Another complicating factor for Alibaba (Symbol : BABA
is that in addition to the 320 million shares being offered, there is an additional 128.4 million in shares - about 5 percent of overall outstanding shares - that are not subject to lock-up agreements that restrict insider sales shortly after an IPO, according to company filings.
That's unusual, and could add some additional selling pressure and increases the incentive for the company to make sure the long-term holders intend to keep their allocation.
I was invited to particitpate in the IPO...weither it fills or not is based on the number of shares my Brokerage company receives.
$68 or not at alll.
I put in an order for the BABA IPO at the $68 price. I doubt it will get filled with my Brokerage account since they were given a limited amount of shares for the IPO.
Does anyone else belive this could be a disappointment due to the fact the original investors have no lock up period and will dump tomorrow? I am thinking abut canceling my confirmation.
I sold 1/2 my position and won't be buying the shares back until Ron and company give some presentations and the analysts get on board.
The stock market in eis dicey right now between geo-polical concerns and the Fed. ..not a great time to buy anything. I have raised cash.
I hope so, but this might be too little too late. There has been alot of damage done as far as PPS and negative articles from places like Barron's, NYT etc.
I have been kicking myself for being greedy and not selling at the $17-18 range...I'm sure I'm not alone..
Sentiment: Strong Buy
You can read this on Seeking Alpha...Yahoo doesn not let you post this.
SA Transcripts, Recent earnings call transcripts (33,216 clicks)
We cover over 5K calls/quarter
Profile| Send Message| Follow (2,526 followers)
Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur Discusses the approval of Ferric Citrate (Transcript)
Sep. 8, 2014 1:18 PM ET | About: Keryx Biopharmaceuticals, Inc. (KERX)
Yes. I was not happy to see this. I am not the only biotech investor that gets their weekly updates. Not a positive article.
I am hoping for the best on Monday.
I have a very low cost basis since i bought 5 years ago but the sell off was not fun to watch.